Concepedia

Ultan McDermott

UM

100

Publications

34.1K

Citations

63

H-Index

2002

Active since

Affiliations

Wellcome Sanger Institute(Current)

Massachusetts General Hospital

Harvard University

University of Cambridge

European Bioinformatics Institute

Ultan McDermott is an author at Wellcome Sanger Institute specializing in medicine, cancer research, and tumor biology.

Top concepts

MedicineCancer ResearchOncologyTumor BiologyCell BiologySystems BiologyTumor MicroenvironmentRadiation OncologyMolecular DiagnosticsPathology

Publications per year

2002–2024

100

Publications

100

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

Wanjuan Yang, Jorge Soares, Patricia Greninger et al. · Nucleic Acids Research · 2012 · 4.2K citations · Full text

Therapeutic Biomarker Discovery, Drug Target, Engineering +21

Pan-cancer analysis of whole genomes

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse et al. · Nature · 2020 · 3.1K citations · Full text

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

Sreenath V. Sharma, Diana Lee, Bihua Li et al. · Cell · 2010 · 2.7K citations · Full text

Chromatin, Chromatin Remodeling, Medicine +6

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J. Garnett, Elena J. Edelman, Sonja J. Heidorn et al. · Nature · 2012 · 2.5K citations · Full text

Systematic Identification, Genomic Markers, Engineering +12

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

Simon Forbes, David Beare, Prasad Gunasekaran et al. · Nucleic Acids Research · 2014 · 2.4K citations · Full text

Rows per page

1–5 of 100